These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 31018949

  • 1. Altered Expression of DDR1 in Clear Cell Renal Cell Carcinoma Correlates With miR-199a/b-5p and Patients' Outcome.
    Krazinski BE, Kiewisz J, Sliwinska-Jewsiewicka A, Kowalczyk AE, Grzegrzolka J, Godlewski J, Kwiatkowski P, Dziegiel P, Kmiec Z.
    Cancer Genomics Proteomics; 2019; 16(3):179-193. PubMed ID: 31018949
    [Abstract] [Full Text] [Related]

  • 2. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A.
    Oncotarget; 2016 Feb 16; 7(7):7683-700. PubMed ID: 26655502
    [Abstract] [Full Text] [Related]

  • 3. MiRNA-199a-5p Protects Against Cerebral Ischemic Injury by Down-Regulating DDR1 in Rats.
    Li M, Luan L, Liu Q, Liu Y, Lan X, Li Z, Liu W.
    World Neurosurg; 2019 Nov 16; 131():e486-e494. PubMed ID: 31382062
    [Abstract] [Full Text] [Related]

  • 4. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
    Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S.
    Mol Cancer; 2010 Aug 27; 9():227. PubMed ID: 20799954
    [Abstract] [Full Text] [Related]

  • 5. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z, Zhao S, Luo L, Xiang Q, Zhu Z, Wang J, Liu Y, Luo J.
    Br J Cancer; 2021 Mar 27; 124(5):982-994. PubMed ID: 33239676
    [Abstract] [Full Text] [Related]

  • 6. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE, Krazinski BE, Godlewski J, Grzegrzolka J, Kiewisz J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Dziegiel P, Kmiec Z.
    Cancer Genomics Proteomics; 2016 Mar 27; 13(3):209-17. PubMed ID: 27107063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
    Deng Y, Zhao F, Hui L, Li X, Zhang D, Lin W, Chen Z, Ning Y.
    J Ovarian Res; 2017 Jul 25; 10(1):50. PubMed ID: 28743276
    [Abstract] [Full Text] [Related]

  • 9. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG, Tolkach Y, Deng M, Schmidt D, Perner S, Kristiansen G, Müller SC, Ellinger J.
    Clin Epigenetics; 2018 Jul 25; 10():11. PubMed ID: 29410711
    [Abstract] [Full Text] [Related]

  • 10. MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling.
    Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F, Jiang J, Tang Z.
    Dig Dis Sci; 2014 Sep 25; 59(9):2163-72. PubMed ID: 24711074
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis.
    Lu J, Chen Y, Wen L, Zhou Q, Yan S.
    J Gene Med; 2022 Jan 25; 24(1):e3389. PubMed ID: 34559933
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
    Outeiro-Pinho G, Barros-Silva D, Aznar E, Sousa AI, Vieira-Coimbra M, Oliveira J, Gonçalves CS, Costa BM, Junker K, Henrique R, Jerónimo C.
    J Exp Clin Cancer Res; 2020 Jun 01; 39(1):98. PubMed ID: 32487203
    [Abstract] [Full Text] [Related]

  • 14. MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma.
    Liu J, Liu B, Guo Y, Chen Z, Sun W, Gao W, Wu H, Wang Y.
    Pathol Res Pract; 2018 Jun 01; 214(6):806-813. PubMed ID: 29773428
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M, Sun Y, Xu J, Lu J, Wang K, Yang DR, Yang G, Li G, Chang C.
    Int J Cancer; 2018 Jul 01; 143(1):100-112. PubMed ID: 29396852
    [Abstract] [Full Text] [Related]

  • 18. miR-4429 Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting CDK6 in Clear Cell Renal Cell Carcinoma.
    Pan H, Hong Y, Yu B, Li L, Zhang X.
    Cancer Biother Radiopharm; 2019 Jun 01; 34(5):334-341. PubMed ID: 30844301
    [Abstract] [Full Text] [Related]

  • 19. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
    Zhang J, Ye Y, Chang DW, Lin SH, Huang M, Tannir NM, Matin S, Karam JA, Wood CG, Chen ZN, Wu X.
    Am J Pathol; 2018 Nov 01; 188(11):2487-2496. PubMed ID: 30201497
    [Abstract] [Full Text] [Related]

  • 20. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma.
    Kim BK, Kim I, Yoon SK.
    J Dermatol Sci; 2015 Aug 01; 79(2):137-47. PubMed ID: 26026896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.